1. British Society for Immunology. Allergy briefing. Retrieved 28 June 2024
https://www.immunology.org/policy-and-public-affairs/briefings-and-position-statements/allergy
2. Lin CF, Lin YT, Liao CK et al. Recent Updates of Immunotherapy for Allergic Rhinitis in Children. Curr Otorhinolaryngol Rep 11, 37–43 (2023). doi.org/10.1007/s40136-023-00440-x
https://rdcu.be/dMbzQ
3. Alvaro-Lozano M, Akdis CA, Akdis, M, Alviani C, Angier E, Arasi S, Arzt-Gradwohl L, Barber D, Bazire R, Cavkaytar O, Comberiati P, Dramburg S, Durham SR, Eifan AO, Forchert L, Halken S, Kirtland M, Kucuksezer UC, Layhadi JA, Matricardi PM, Muraro A, Ozdemir C, Pajno GB, Pfaar O, Potapova E, Riggioni C, Roberts G, Rodríguez del Río P, Shamji MH, Sturm GJ, Vazquez-Ortiz M. Allergen Immunotherapy in Children User’s Guide. Pediatr Allergy Immunol. 2020: 31(Suppl. 25): 1-101. doi.org/10.1111/pai.13189
https://onlinelibrary.wiley.com/doi/epdf/10.1111/pai.13189
4. [CA] Moote W, Kim H, Ellis AK. Allergen-specific immunotherapy. Allergy Asthma Clin Immunol 14 (Suppl 2), 53 (2018). doi.org/10.1186/s13223-018-0282-5
https://aacijournal.biomedcentral.com/articles/10.1186/s13223-018-0282-5
5. [EU] Roberts G, Pfaar O, Akdis A, Ansotegui IJ, Durham SR, Gerth van Wijk R, Halken S, Larenas-Linnemann D, Pawankar R, Pitsios C, Sheikh A, Worm M, Arasi S, Calderon MA, Cingi C, Dhami S, Fauquert JL, Hamelmann E, Hellings P, Jacobsen L, Know EF, Lin SY, Maggina P, Mösges R, Oude Elberink JNG, Pajno GB, Pastorello EA, Penagos M, Rotiroti G, Schmidt-Weber CB, Timmermans F, Tsilochristou O, Varga E-M, Wilkinson JN, Williams A, Zhang L, Agache I, Angier E, Fernandez-Rivas M, Jutel M, Lau S, van Ree R, Ryan D, Sturm GJ, Muraro A. European Journal of Allergy and Clinical Immunology (EAACI) Guidelines on Allergen Immunotherapy. Allergic rhinoconjunctivitis. 23 September 2017. doi.org/10.1111/all.13317
https://onlinelibrary.wiley.com/doi/10.1111/all.13317
6. [CA] Quirt J, Gagnon R, Ellis AK, Kim HL. CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens. Allergy Asthma Clin Immunol. 2018;14:1. Published 2018 Jan 9. doi:10.1186/s13223-017-0225-6
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759887/
7. [US] Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, Nelson M, Weber R, Bernstein DI, Blessing-Moore J, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles S, Wallace D. Allergen immunotherapy. A practice parameter third update. Journal of Allergy and Clinical Immunology. 2011 Jan;127(1Suppl):S1-55. PMID: 21122901. doi:10.1016/j.jaci.2010.09.034
https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Allergen-immunotherapy-Jan-2011.pdf
8. Aggarwal P, Senthilkumaran S. Dust Mite Allergy. [Updated 2023 May 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan
https://www.ncbi.nlm.nih.gov/books/NBK560718/
9. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy ClinImmunol. 2007;120(2):381-387. doi:10.1016/j.jaci.2007.03.034
https://www.sciencedirect.com/science/article/pii/S009167490700632X?via%3Dihub
10. Trivedi M, Denton E. ‘Asthma in Children and Adults—What Are the Differences and What Can They Tell us About Asthma?’, Frontiers in Pediatrics. 2019 June, 7(256). doi: 10.3389/fped.2019.00256
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603154/
11. Doroudchi, A, Imam K, Garcia Lloret MI. Allergen Immunotherapy in Pediatric Respiratory Allergy. Curr Treat Options Allergy 8, 147–160 (2021). doi.org/10.1007/s40521-021-00280-4
https://link.springer.com/article/10.1007/s40521-021-00280-4#citeas
12. MedlinePlus. Allergic asthma. Retrieved 28 June 2024
https://medlineplus.gov/genetics/condition/allergic-asthma/
13. Reinwald S, Rolland JM, O'Hehir RE, van Zelm MC. Peanut oral immunotherapy: current trends in clinical trials. Immunother Adv. 2022;2(1):ltac004. Published 2022 Jan 31. doi:10.1093/immadv/ltac004
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327116/
14. Tsuge M, Ikeda M, Matsumoto N, Yorifuji T, Tsukahara H. Current Insights into Atopic March. Children. 2021; 8(11):1067. https://doi.org/10.3390/children8111067
https://www.mdpi.com/2227-9067/8/11/1067
15. Asllani J, Mitsias D, Konstantinou G, et al. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce. Clin Transl Allergy. 2023;13(6):e12250. doi:10.1002/clt2.12250
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236500/
16. Great Ormond Street Hospital for Children. Distraction: Information for families. Retrieved 2 July 2024
https://media.gosh.nhs.uk/documents/Distraction_F0617_FINAL_Jun20.pdf
17. Nolte H, Maloney J. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases. Allergol Int. 2018 Jul;67(3):301-308. doi: 10.1016/j.alit.2018.03.008. Epub 2018 May 16
https://www.ncbi.nlm.nih.gov/pubmed/29759659